Inventor
LUO YUNFU
CN41 patents
⚠️ This page may combine multiple inventors who share the name “LUO YUNFU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
19 patentsUS10189831B2Jan 29, 2019
Non-nucleoside reverse transcriptase inhibitors
MERCK SHARP & DOHME75 citations96
US9695163B2Jul 4, 2017
Thiazole orexin receptor antagonists
MERCK SHARP & DOHME8 citations83
US10239838B2Mar 26, 2019
Heteroaryl orexin receptor antagonists
MERCK SHARP & DOHME0 citations52
US10150751B2Dec 11, 2018
Pyrrolidine orexin receptor antagonists
MERCK SHARP & DOHME1 citations52
US9828368B2Nov 28, 2017
Oxazole orexin receptor antagonists
MERCK SHARP & DOHME1 citations51
US9981969B2May 29, 2018
Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
MERCK SHARP & DOHME0 citations50
US9718819B2Aug 1, 2017
Non-nucleoside reverse transcriptase inhibitors
MERCK SHARP & DOHME1 citations49
US10435398B2Oct 8, 2019
Oxazole orexin receptor antagonists
MERCK SHARP & DOHME0 citations42
US10227336B2Mar 12, 2019
Pyrazole orexin receptor antagonists
MERCK SHARP & DOHME0 citations42
US10214535B2Feb 26, 2019
Hydroxmethyl piperidine orexin receptor antagonists
MERCK SHARP & DOHME0 citations42
US10155750B2Dec 18, 2018
Amidoethyl azole orexin receptor antagonists
MERCK SHARP & DOHME0 citations42
US9920038B2Mar 20, 2018
Methyl oxazole orexin receptor antagonists
MERCK SHARP & DOHME0 citations42
US10526336B2Jan 7, 2020
Fused heteroaryl derivatives as orexin receptor antagonists
MERCK SHARP & DOHME0 citations41
US10308645B2Jun 4, 2019
Piperidine oxadiazole and thiadiazole orexin receptor antagonists
MERCK SHARP & DOHME0 citations41
US10745377B2Aug 18, 2020
Piperidine or piperazine linked imidazole and triazole derivatives and methods of use
MERCK SHARP & DOHME0 citations40
US9975888B2May 22, 2018
Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
MERCK SHARP & DOHME0 citations40
US9556202B2Jan 31, 2017
Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug
MERCK SHARP & DOHME0 citations39
US10017504B2Jul 10, 2018
Piperidine isoxazole and isothiazole orexin receptor antagonists
MERCK SHARP & DOHME0 citations38
US10010539B2Jul 3, 2018
Pyrazole, triazole and tetrazole orexin receptor antagonists
MERCK SHARP & DOHME0 citations37
MEDSHINE DISCOVERY INC
9 patentsUS11136315B2Oct 5, 2021
CXCR2 antagonist
MEDSHINE DISCOVERY INC2 citations71
US11325907B2May 10, 2022
Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor
MEDSHINE DISCOVERY INC0 citations61
US12466816B2Nov 11, 2025
Fused cyclic compound capable of degrading protein and use thereof
MEDSHINE DISCOVERY INC0 citations60
US12338218B2Jun 24, 2025
Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of solvate thereof, and preparation method thereof
MEDSHINE DISCOVERY INC0 citations60
US10532986B2Jan 14, 2020
Cyclic compound acting as PDE4 inhibitor
MEDSHINE DISCOVERY INC1 citations59
US11905276B2Feb 20, 2024
Bicyclic compound that acts as CRBN protein regulator
MEDSHINE DISCOVERY INC1 citations58
US12545648B2Feb 10, 2026
Benzopyrazole compound
MEDSHINE DISCOVERY INC0 citations50
US11319330B2May 3, 2022
Tricyclic furan-substituted piperidinedione compound
MEDSHINE DISCOVERY INC0 citations49
US11155523B2Oct 26, 2021
Biphenyl compound as CCR2/CCR5 receptor antagonist
MEDSHINE DISCOVERY INC0 citations46